Review
Open access
Aug 2026
Antibody–drug conjugate development in lymphoma: a systematic clinical trial landscape analysis
Lymphoma ADC development has expanded, but trial growth has outpaced platform diversification and the generation of confirmatory evidence; future priorities include subtype-specific targeting, platform diversification, randomized comparative studies, standardized safety reporting, biomarker-guided patient selection, an...
Heng-Rui Zhang, Jincheng Li, Han-Xi Yan et al.
· Frontiers in Immunology · 0 citations